If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
70.50    -0.50 (-0.70%)
Bid:
69.00
Ask:
72.00
Spread: 3.00 (4.348%)
Market Cap: £66.81m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Issue of Shares

11 Nov 2022 07:00

RNS Number : 0606G
TPXimpact Holdings PLC
11 November 2022
 

 

 

11 November 2022

TPXimpact Holdings PLC

("TPX", "TPXimpact", or the "Company")

 

Issue of Shares

 

TPXimpact Holdings PLC (AIM: TPX), the technology-enabled services company focused on digital transformation, announces that the Company has today issued 30,898 new ordinary shares of 1 pence each in respect of the Share Incentive Plan ("SIP").

 

The SIP Trustees (Cytec Trustees Limited) acquired a total of 30,898 shares (the "Partnership Shares") on 8 November 2022 at a price of £0.394 per Ordinary Share and total cost of £12,173.81. The Partnership Shares were acquired by purchase in the market and allocated to those Company employees participating in its Share Incentive Plan (SIP) scheme. As set out at the time of the announcement of TPXimpact's interim results on 30 November 2020, this SIP Plan is designed to reward and incentivise employees of the Company through tax-efficient salary sacrifice and a free matching award of Ordinary Shares on a one-for-one basis.

 

Accordingly, on 10 October 2022, the SIP Trustees also allocated a total of 30,898 matching shares (the "Matching Shares") under the SIP. 19,011 Matching Shares are covered by the Company's block listing as announced on 22 July 2022. For the remaining Matching Shares, an application has been made to the London Stock Exchange for 11,887 new ordinary shares to be admitted to trading on AIM which is expected to take place on or around 15 November 2022.

 

The new Ordinary Shares issued and admitted to trading will rank pari passu in all respects with the existing Ordinary Shares.

 

 

Total voting rights

 

Therefore, following this issue of the Matching Shares, TPXimpact's total issued share capital consists of 91,232,464 ordinary shares of 1 penny each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury. The EBT holds a total of 987,732 Ordinary Shares representing 1.08% of TPX's issued share capital.

 

Therefore, the total number of voting rights in the Company is 90,244,732.

The above figure of 90,244,732 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

TPXimpact Holdings

Bjorn Conway, CEO

Steve Winters, Group CFO

 

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

Alex Price

Fred Walsh

Ben Burnett

 

Via Alma PR

 

 

+44 (0) 207 710 7600

 

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

 

 

+44 (0) 203 903 7715

Alma PR

(Financial PR)

Josh Royston

Kieran Breheny

Matthew Young

tpx@almapr.co.uk

+44 (0) 203 405 0209

 

 

 

About TPXimpact

 

TPXimpact exists to transform the organisations, services and systems that underpin society and that drive business success. It applies strategic and creative thinking, technology, innovative design and user-centred approaches to bring about numerous improvements which together multiply the impact of change.

The Company works closely with its clients in agile, multidisciplinary teams that span organisational design, technology, and digital experiences. It shares a deep understanding of people and behaviours and a philosophy of putting people and communities at the heart of every transformation.

The business is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.72% of its client base representing the public sector and c.28% representing the commercial sector.

More information is available at www.tpximpact.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEVBLFFLFLXFBL
Date   Source Headline
3rd Jul 202610:35 amRNSNotification of Major Holdings
2nd Jul 20268:18 amRNSNotification of Major Holdings
16th Jun 20267:00 amRNSUnaudited preliminary results
11th Jun 20267:00 amRNSShare Incentive Plan
1st Jun 20267:00 amRNSTPXimpact announces £16m contract with the MoJ
11th May 20267:00 amRNSShare Incentive Plan
22nd Apr 20267:00 amRNSFull Year Trading Update and Notice of Results
17th Apr 20264:17 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSShare Incentive Plan
20th Mar 20267:00 amRNSShare Incentive Plan
24th Feb 20267:00 amRNSQ3 Trading Update: EBITDA guidance Upgrade
17th Feb 20267:00 amRNSContract Uplift
12th Feb 20267:01 amRNSTPXimpact announces £39m Contract with DEFRA
12th Feb 20267:00 amRNSShare Incentive Plan
11th Feb 20267:00 amRNSTPXimpact announces £22m NHS England contract
9th Jan 20267:00 amRNSShare Incentive Plan
9th Dec 20257:00 amRNSShare Incentive Plan
8th Dec 20255:19 pmRNSHolding(s) in Company
2nd Dec 20252:45 pmRNSExercise of Options, PDMR, & Total Voting Rights
2nd Dec 20257:00 amRNSUnaudited Interim Results
24th Nov 20257:30 amRNSAppointment of Nominated Adviser and Broker
14th Nov 20257:00 amRNSShare Incentive Plan
5th Nov 20257:00 amRNSFirst Half Update & Notice of Results
14th Oct 20255:29 pmRNSShare Incentive Plan
25th Sep 20254:37 pmRNSResult of AGM
9th Sep 20257:00 amRNSShare Incentive Plan
8th Sep 20255:25 pmRNSExercise of Options & PDMR Dealings
8th Sep 20253:27 pmRNSNotification of Major Holdings
5th Sep 202512:37 pmRNSIssuance of Shares & Total Voting Rights
22nd Aug 20257:00 amRNSNotice of AGM
21st Aug 20257:00 amRNSChange of Auditor
12th Aug 20256:05 pmRNSReplacement: FY25 & FY26 Share Awards
11th Aug 20257:00 amRNSPosting of Annual Report
4th Aug 20259:24 amRNSReplacement: FY25 & FY26 Share Awards
4th Aug 20257:00 amRNSFY25 & FY26 Long-Term Incentive Share Award
30th Jul 20257:00 amRNSDebt Facility Renewal Update
14th Jul 20257:00 amRNSAppointment of non-executive director
10th Jul 20257:00 amRNSShare Incentive Plan
24th Jun 20257:00 amRNSUnaudited preliminary results
16th Jun 20259:00 amRNSNotice of Results
12th Jun 20251:17 pmRNSShare Incentive Plan
14th May 20257:00 amRNSTrading Update and Contract Wins
22nd Apr 20257:00 amRNSResignation of Non-Executive Director
11th Apr 20257:00 amRNSShare Incentive Plan
12th Mar 20257:00 amRNSShare Incentive Plan
28th Feb 20253:26 pmRNSChange of Registered Office Address
12th Feb 20257:00 amRNSShare Incentive Plan
6th Feb 20257:00 amRNSQ3 Trading Update and Revised Outlook
3rd Feb 20257:00 amRNSConfirmation of CFO Appointment
15th Jan 20257:00 amRNSShare Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.